[First report on experience with the combined treatment of thrombosis of the central retinal vein or its branches with an aggregation inhibitor (Colfarit) (author's transl)].
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006025:Glycosaminoglycans / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010973:Platelet Adhesiveness / Q000187:drug effects; D011379:Prognosis; D012166:Retinal Hemorrhage / Q000188:drug therapy; D012169:Retinal Vein; D013924:Thrombophlebitis / Q000188:drug therapy*; D014786:Vision Disorders / Q000517:prevention & control
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006025:Glycosaminoglycans
Erster Erfahrungsbericht in der kombinierten Behandlung der Astvenen- und Zentralvenenthrombose mit einem Aggregationshemmer (Colfarit.